期刊文献+

Tim-1及Tim-3mRNA在胃癌患者外周血单个核细胞中的表达及临床意义 被引量:4

Expression of Tim - 1 and Tim - 3 mRNA in PBMCs from gastric carcinoma patients and its clinical significance
在线阅读 下载PDF
导出
摘要 目的研究T细胞免疫球蛋白黏蛋白1(Tim-1)及T细胞免疫球蛋白黏蛋白3(Tim-3)mRNA在胃癌患者体内的表达与其临床意义。方法采用RT—PCR法分别检测22例胃癌患者及8例正常人外周血单个核细胞中Tim-1及Tim-3mRNA的表达情况,并分析它们与临床各病理参数之间的关系。结果Tim-1mRNA在胃癌中的表达高于正常对照组[(11.38±1.85)比(9.64±1.53)],差异有统计学意义(P〈0.05),且与肿瘤浸润深度、分化程度,淋巴结转移、临床分期有关(P〈0.05),Tim~3mRNA在胃癌中的表达高于正常对照组[(11.74±1.71)比(9.81±1.69)],差异有统计学意义(P〈0.05),但Tim-3mRNA在胃癌中的表达与各病理参数无关(P〉0.05)。结论Tim-1及Tim-3mRNA在胃癌患者中的表达均高于正常对照组,Tim-1mRNA在胃癌患者中的表达还与肿瘤的侵袭转移密切相关,Tim-1及Tim-3有可能成为胃癌基因治疗的新靶点。 Objective To explore the expression of Tim - 1 and Tim - 3 mRNA in PBMCs from gastric carcinoma patients and its clinical significance. Methods The expression of Tim - 1 and Tim -3 mRNA was detected by fluorescent quantitative real time RT - PCR in 22 gastric carcinoma patients and 8 normal subjects. The association of the expressions with clinical - pathological indicators was examined. Results The expression of Tim - 1 in the PBMCs from gastric carcinoma patients was higher than that from normal controls ( 11.38 ± 1.85 vs 9.64 ± 1.53) ( P 〈 0. 05 ). The expression of Tim - 1 was closely related to the depth of invasion, tumor differentiation, lymph node metastasis and TNM stages (P 〈 0.05 ). The expression of Tim - 3 in the PBMCs from gastric carcinoma patients was higher than that from normal controls ( 11.74 ± 1.71 vs 9.81 ± 1.69) (P 〈 0.05 ), but the expression of Tim - 3 showed no close relationship with the clinical - pathological indicators. Conclusion Tim - 1 and Tim - 3 may be involved in the occurrence and development of gastric cancer and become new targets for gene therapy of gastric cancer.
出处 《临床外科杂志》 2010年第6期386-388,共3页 Journal of Clinical Surgery
基金 湖北省自然科学基金资助项目(编号:2005ABA121)
关键词 T细胞免疫球蛋白黏蛋白1 T细胞免疫球蛋白黏蛋白3 胃癌 TH1/TH2 Tim - 1 Tim - 3 gastric carcinoma Th1/Th2
作者简介 苏锦松(1982-),男,硕士。 通讯作者:孙华文,Email:sunhuawen888@163.com
  • 相关文献

参考文献5

  • 1Umetsu SE,Wang-Ling L,Mclntire JJ,et al.Tim-1 induces T cell activation and inhibits the development of peripheral tolerance[J].Nat Immunol,2005,6(5):447-454.
  • 2Encinas JA,Janssen EM,Weiner DB,et al.Anti-T-cell Ig and mucin domain containing protein 1 antibody decreases TH2 airway inflammation in a mouse model of asthma[J].J Allergy Clin Immunol,2005,116(6):1343-1349.
  • 3Zhu C,Anderson AC,Schubart A,et al.The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity[J].Nat Immunol,2005,6(12):1245-1252.
  • 4Gielen AW,Lobell A,Lidman O,et al.Expression of T cell immunoglobulin-and mucin-domain-containing molucules-1 and -3(TIM-1 and -3)in the rat nervous and immune systems[J].Neuroimmunol,2005,164(1-2):93-104.
  • 5Meari M,Smithson G,Ghatpande A,et al.Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins[J].Int Immunol,2006,18(3):473-484.

同被引文献31

  • 1Chia-Hsun Lu,Hsuan-Ying Huang,Han-Koo Chen,Jiin-Haur Chuang,Shu-Hang Ng,Sheung-Fat Ko.Huge pelvi-abdominal malignant inflammatory myofibroblastic tumor with rapid recurrence in a 14-year-old boy[J].World Journal of Gastroenterology,2010,16(21):2698-2701. 被引量:9
  • 2Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galec- tin-9 negatively regulates T helper type 1 immunity. Nat Immunol, 2005, 6(12) : 1245-1252.
  • 3Freeman GJ, Casasnovas JM, Umetsu DT, et al. TIM genes: a family of cell surface phosphatidylserine receptors that regulate in- nate and adaptive immunity. Immunol Rev, 2010, 235 (1) : 172- 189.
  • 4Dogan RN, Vasu C, Holterman M J, et al. Absence of IL-4, and not suppression of the Th2 response, prevents development of ex-perimental autoimmune Graves' disease. J Immunol, 2003, 170: 2195-2204.
  • 5Xia N, Zhou S, Liang Y, et al. CIM+ T cells and the Thl/Th2 imbalance are implicated in the pathogenesis of Graves' ophthal- mopathy. Int J Mol Med, 2006, 17(5) : 911-916.
  • 6Aust G, Kamprad M, Lamesch P, et al. CXCR6 within T-helper (Th) and T-cytotoxic (Tc) type 1 lymphocytes in Graves' disease (GD). Eur J Endocrinol, 2005, 152(4): 635-643.
  • 7Inukai Y, Momobayashi A, Sugawara N, et al. Changes in ex- pression of T-helper (Th) 1- and Th2-associated chemokine re- ceptors on peripheral blood lymphocytes and plasma concentrations of their ligands, imerferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administra- tion in hyperthyroid patients with Graves' disease. Eur J Endocri- nol, 2007, 156(6) : 623-630.
  • 8Han R, Smith TJ. T helper type 1 and type 2 cytokines exert di- vergent influence on the induction of prostaglandin E2 and hyaluro- nan synthesis by interleukin-1 beta in orbital fibroblasts: implica- tions for the pathogenesis of thyroid-associated ophthalmopathy. Endocrinology, 2006, 147( 1 ) : 13-19.
  • 9Borgogni E, Sarchielli E, Sottili M, et al. Elocalcitol inhibits in- flammatory responses in human thyroid cells and T cells. Endocri- nology, 2008, 149(7) : 3626-3634.
  • 10Bahn RS. Graves' ophthalmopathy. N Engl J Med, 2010, 362(8) : 726-738.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部